SE302020B - - Google Patents
Info
- Publication number
- SE302020B SE302020B SE3745/64A SE374564A SE302020B SE 302020 B SE302020 B SE 302020B SE 3745/64 A SE3745/64 A SE 3745/64A SE 374564 A SE374564 A SE 374564A SE 302020 B SE302020 B SE 302020B
- Authority
- SE
- Sweden
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
- E01C—CONSTRUCTION OF, OR SURFACES FOR, ROADS, SPORTS GROUNDS, OR THE LIKE; MACHINES OR AUXILIARY TOOLS FOR CONSTRUCTION OR REPAIR
- E01C7/00—Coherent pavings made in situ
- E01C7/08—Coherent pavings made in situ made of road-metal and binders
- E01C7/18—Coherent pavings made in situ made of road-metal and binders of road-metal and bituminous binders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB11742/63A GB1023495A (en) | 1963-03-25 | 1963-03-25 | X-ray contrast media |
| US30016763A | 1963-08-06 | 1963-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE302020B true SE302020B (en:Method) | 1968-07-01 |
Family
ID=26248484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE3745/64A SE302020B (en:Method) | 1963-03-25 | 1964-03-25 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3325370A (en:Method) |
| AT (1) | AT255642B (en:Method) |
| BE (1) | BE645634A (en:Method) |
| BR (1) | BR6457861D0 (en:Method) |
| CH (1) | CH432726A (en:Method) |
| DE (1) | DE1207048B (en:Method) |
| DK (1) | DK106196C (en:Method) |
| ES (1) | ES297858A1 (en:Method) |
| FI (1) | FI41591B (en:Method) |
| FR (1) | FR3862M (en:Method) |
| GB (1) | GB1023495A (en:Method) |
| IT (1) | IT1029502B (en:Method) |
| NL (2) | NL6403181A (en:Method) |
| SE (1) | SE302020B (en:Method) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855405A (en) * | 1969-11-26 | 1974-12-17 | Squibb & Sons Inc | Radiographic contrast composition containing 2{40 ,6{40 -diiodo-dl-thyronine and methods of use thereof |
| AT371998B (de) * | 1978-07-04 | 1983-08-25 | Nyegaard & Co As | Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels |
| GB9020091D0 (en) * | 1990-09-14 | 1990-10-24 | Nycomed As | Contrast media |
| GB2465663A (en) * | 2008-11-26 | 2010-06-02 | Ge Healthcare As | X-ray contrast agent compositions comprising an iodinated X-ray contrast agent and ethylenediamine-N,N-disuccinic acid |
| US20140065076A1 (en) * | 2012-08-30 | 2014-03-06 | Otsuka Pharmaceutical Co. Ltd. | Container with concentrated substance and method of using the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2921884A (en) * | 1957-09-30 | 1960-01-19 | Sterling Drug Inc | Pharmaceutical compositions |
| US3175952A (en) * | 1963-05-29 | 1965-03-30 | Sterling Drug Inc | Aqueous radiopaque solutions containing sodium and calcium ions |
-
0
- NL NL127881D patent/NL127881C/xx active
-
1963
- 1963-03-25 GB GB11742/63A patent/GB1023495A/en not_active Expired
-
1964
- 1964-03-16 US US352719A patent/US3325370A/en not_active Expired - Lifetime
- 1964-03-20 FI FI0617/64A patent/FI41591B/fi active
- 1964-03-21 ES ES297858A patent/ES297858A1/es not_active Expired
- 1964-03-21 IT IT05922/64A patent/IT1029502B/it active
- 1964-03-23 CH CH372764A patent/CH432726A/de unknown
- 1964-03-23 DK DK146264AA patent/DK106196C/da active
- 1964-03-24 BE BE645634D patent/BE645634A/xx unknown
- 1964-03-24 BR BR157861/64A patent/BR6457861D0/pt unknown
- 1964-03-25 NL NL6403181A patent/NL6403181A/xx unknown
- 1964-03-25 AT AT261364A patent/AT255642B/de active
- 1964-03-25 FR FR968615A patent/FR3862M/fr not_active Expired
- 1964-03-25 DE DEN24680A patent/DE1207048B/de active Pending
- 1964-03-25 SE SE3745/64A patent/SE302020B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL6403181A (en:Method) | 1964-09-28 |
| DE1207048B (de) | 1965-12-16 |
| CH432726A (de) | 1967-03-31 |
| BR6457861D0 (pt) | 1973-12-26 |
| FI41591B (en:Method) | 1969-09-01 |
| GB1023495A (en) | 1966-03-23 |
| ES297858A1 (es) | 1964-09-01 |
| FR3862M (fr) | 1966-01-24 |
| NL127881C (en:Method) | |
| IT1029502B (it) | 1979-03-20 |
| AT255642B (de) | 1967-07-10 |
| US3325370A (en) | 1967-06-13 |
| DK106196C (da) | 1967-01-02 |
| BE645634A (en:Method) | 1964-07-16 |